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Abstract 
The investigation of a difluoromethyl-bearing nucleoside with the fluorinase enzyme is 
described. 5',5'-Difluoro-5'-deoxyadenosine 7 (F2DA) was synthesised from adenosine, and 
found to bind to the fluorinase enzyme by isothermal titration calorimetry with similar affinity 
compared to 5'-fluoro-5'-deoxyadenosine 2 (FDA), the natural product of the enzymatic 
reaction. F2DA 7 was found, however, not to undergo the enzyme catalysed reaction with 
L-selenomethionine, unlike FDA 2, which undergoes reaction with L-selenomethionine to 
generate Se-adenosylselenomethionine. A co-crystal structure of the fluorinase and F2DA 7 and 
tartrate was solved to 1.8 Å, and revealed that the difluoromethyl group bridges interactions 
known to be essential for activation of fluoride for reaction. An unusual hydrogen bonding 
interaction between the hydrogen of the difluoromethyl group and one of the hydroxyl oxygens 
of the tartrate ligand was also observed. The bridging interactions, coupled with the inherently 
stronger C–F bond in the difluoromethyl group, offers an explanation for why no reaction is 
observed.  
Keywords: fluorinase, difluoromethyl, isothermal titration calorimetry, protein crystallography 
1. Introduction 
The fluorinase enzyme, isolated originally from the soil bacterium Streptomyces cattleya1 and recently 
identified in additional bacterial species,2 catalyses formation of a C–F bond from fluoride ion and 
S-adenosylmethionine 1 (SAM), generating 5'-fluoro-5'-deoxyadenosine 2 (FDA) (Scheme 1). The 
reaction has been shown to proceed by an inversion of configuration,3,4 and QM/MM calculations 
provide strong support for an SN2 reaction mechanism.5 The fluorination reaction is reversible, and 
the enzyme has the capacity to produce SAM 1 and fluoride ion when incubated with FDA 2 and L-
methionine.6 The fluorinase is of interest to biotechnology through its use as a biocatalyst for the 
introduction of fluorine into organic molecules, and this ability has been exploited using [18F]fluoride 
for the synthesis of PET radiotracers.7–10 The difluoromethyl and fluoromethyl groups remain 
comparatively unexplored in terms of their application to bioactive molecules.11 Enzymatic synthesis 
of the fluoromethyl group (R–CH2F) has been extensively explored,12 and we were interested in 
exploiting the ability of the fluorinase to activate fluoride ion in water, to extend fluorinase 
biocatalysis to the synthesis of a difluoromethyl group (R–CF2H) from an appropriate substrate. 
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Scheme 1. The reversible synthesis of a C–F bond from fluoride and S-adenosylmethionine 1 (SAM) by the fluorinase 
enzyme. 
The difluoromethyl group is of interest for introduction into bioactive molecules as it bears a 
hydrogen atom which is available as a hydrogen bond donor, although a more lipophilic hydrogen 
bond donor than the more common hydrophilic O–H and N–H groups.13 The lipophilic hydrogen 
bonding capacity of the difluoromethyl group has led to its development as a bio-isostere of 
alcohols,14 thiols15 and hydroxamic acids.16 Routes to access the difluoromethyl motif involve reaction 
of an aldehyde with sulfur tetrafluoride,17 reaction of nucleophilic “RCF2-” species with 
electrophiles,18–21 reaction of a nucleophilic C, S, N, or O nucleophiles with difluorocarbene,22–26 or 
transfer of a difluoromethyl radical to an appropriate substrate.27–29 
To explore the enzymatic synthesis of a difluoromethyl group, an appropriate substrate was required. 
To investigate the putative transformation in the forward direction, an S-adeonosylmethionine 
analogue bearing a fluorine atom at the 5'-position would be required, however such 5'-modified SAM 
derivatives have not been reported. Simple α-fluorosulfonium species, including 
(fluoromethyl)dimethylsulfonium tetrafluoroborate,30 and diaryl fluoromethylsulfonium salts31 have 
been investigated as electrophiles, suggesting that the motif may be susceptible to attack by a suitably 
activated fluoride nucleophile. While the literature reports of the α-fluorosulfonium motif suggested 
that fluorinated SAM derivative may be thermodynamically stable, synthesis of this highly 
functionalised substrate would not be trivial.  
We envisioned utilising the fluorinase-catalysed reaction in the reverse direction, where incubation of 
a difluoromethylated substrate (F2DA 7) was proposed to generate a fluoro-SeSAM intermediate upon 
reaction with L-selenomethionine6 as the incoming nucleophile. In this paper, we describe a modified 
synthesis of F2DA 7, and an exploration of this putative substrate for selective substitution of one of 
the fluorine atoms of a difluoromethyl group, attempting to capitalise on the fluoride-activating 
properties of the fluorinase enzyme.  
2. Results and Discussion 
2.1. Synthesis of F2DA 7 
The synthesis of 5',5'-difluoro-5'-deoxyadensine 7 has been previously reported by Jarvi et al,32,33 
where fluorination of N,N-dibenzoyl-2',3'-O-isopropylidneadenosine-5'-aldehyde 5 with 
diethylaminosulfur trifluoride (DAST) was the key fluorination step. In a modified version of their 
synthesis, adenosine 3 was protected as its 2',3'-acetonide with 2,2-dimethoxypropane in acetone, 
catalysed by perchloric acid, as shown in Scheme 2. The resultant acetonide was dibenzoylated in 
excellent yield with TMSCl, and an excess of benzoyl chloride to furnish 4. Oxidation of 4 under 
Moffatt conditions, but substituting DCC for EDCI.HCl, gave excellent conversion of the alcohol to a 
mixture of aldehyde 5 and its hydrate, without the requirement for trapping as the aminal as reported 
by Jarvi et al.32,33 Azeotropic removal of water by repeated co-evaporation with toluene furnished 
aldehyde 5 in quantitative yield, which was used without further purification. 
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Scheme 2. Synthesis of F2DA 7. 
Jarvi et al32,33 report a low yield for the fluorination of 5 (18%) using DAST in DCM, however, we 
found that use of the reported conditions led to the formation of multiple fluorinated by-products. 
After optimisation of the reaction conditions, fluorination of aldehyde 5 with Deoxofluor® in THF 
furnished 6 with fewer fluorinated by-products, ultimately offering 6 in 10% yield after purification, 
With protected F2DA 7 in hand, the benzoyl groups were cleaved by reaction of 6 with a freshly 
saturated solution of ammonia in methanol, in a sealed tube at 60 °C for 16 h. After isolation, the 
resultant acetonide was hydrolysed in a mixture of TFA and water, to provide F2DA 7 as a colourless 
powder, in good yield. With a sample of F2DA 7 in hand, we set out to explore its interaction with the 
fluorinase enzyme. 
2.2. Isothermal titration calorimetry 
The binding of F2DA 7 to the fluorinase was investigated using isothermal titration calorimetry (ITC). 
Accordingly, a solution of F2DA 7 in a phosphate buffer was titrated into a solution of the fluorinase 
in the same buffer. The binding curve obtained is illustrated below in Figure 1 A, and the data was 
fitted to a 1:1 isotherm assuming a single binding site. A similar experiment was conducted by 
titrating FDA 2, the natural substrate, into the fluorinase for comparison, and the resultant titration 
curve is illustrated in Figure 1 B. The titration curve revealed that F2DA 7 exhibited strong binding to 
the fluorinase. The association constant (Ka) for this interaction was calculated to be 
27.1 ± 2.01 × 105 M−1. Comparison of the association constant with that of FDA 2 revealed that F2DA 
7 bound with slightly higher affinity for the fluorinase, by a factor of nearly two. Both compounds 
show favourable enthalpic contributions, but F2DA 7 shows a greater exotherm upon binding, likely 
due to increased lipophilicity of the difluoromethyl group compared to the fluoromethyl group. The 
greater enthapic contribution for F2DA 7 is compensated for by a larger entropic penalty, which 
results in the similar nett free energy change to that observed for FDA 2. The presence of the second 
fluorine substituent at C-5' appears to increase the affinity of the nucleoside for the enzyme.  
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Figure 1. Isothermal titration calorimetric determination of the binding affinity of A. F2DA 7 (0.72 mM) into the fluorinase 
(60.3 µM) and B. FDA 2 (1.03 mM) into the fluorinase (53.6 µM). 
2.3. Incubation of F2DA 7 with the fluorinase 
Confident that the candidate substrate, F2DA 7, binds to the enzyme, attention turned to investigating 
whether the fluorinase was able to catalyse substitution of one of the fluorine atoms of with L-
selenomethionine (L-SeMet) rather than L-methionine. Selenium (Se) is a better nucleophile34 than 
sulfur due to the presence of a higher energy HOMO on the selenium atom, and the increased 
polarizability of Se over S.35 In addition, it has previously been demonstrated that, in the reverse 
direction, the fluorinase catalysed reaction between FDA 2 and L-SeMet occurs 6-fold faster6 than 
with the L-Met, suggesting that assays with L-SeMet are better suited for investigating putative 
substrates. The anticipated transformation of F2DA 7 to FSeSAM 8 is illustrated below in Scheme 3. 
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Scheme 3. Exploration of the enzymatic transformation of F2DA 7 to its corresponding FSeAM analogue 8. 
F2DA 7 was incubated with L-SeMet (0.6 mM) and the fluorinase enzyme in phosphate buffer in 
similar experiments to those described above. Reaction progress was again monitored by HPLC at 
t = 0, 1, 2, and 19 h, and the results are illustrated in Figure 2. The HPLC trace did not reveal any 
change in the concentration of F2DA 7 over 19 h, and there were no significant new peaks evident in 
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the chromatogram. A similar experiment, substituting L-Met for L-SeMet did not result in any 
conversion to new products. This data suggested that the fluorinase is not capable of catalysing the 
proposed substitution. 
 
Figure 2. HPLC time course of incubation of F2DA 7 with L-SeMet (0.6 mM) and the fluorinase, with samples taken at t = 0, 
1, 2 and 19 h. The chromatograms show no change in concentration of F2DA 7, and no new products were evident, 
suggesting that F2DA 7 is not a substrate for the fluorinase enzyme. 
The lack of any obvious reaction with either L-Met or L-SeMet suggested that the inherent properties 
of F2DA 7, possibly steric or electronic, or a combination thereof, prevents substitution of one of the 
fluorine atoms at C-5'. As the fluorinase reaction is known to be reversible, the possibility also exists 
that the equilibrium for this transformation lies far in favour of the difluorinated product. Without 
access to synthetic samples of a 5'-fluoro-SAM or its selenium analogue, distinguishing between 
equilibrium effects or inherent lack of reactivity is not straightforward. 
2.4. Crystallography of F2DA 7 with the fluorinase 
To further probe the binding of F2DA 7 to the enzyme and to try to understand the lack of reactivity, 
conditions were explored for the preparation of a fluorinase-F2DA 7 co-crystal. A co-crystal suitable 
for diffraction was obtained and a structure solved to a resolution of 1.8 Å (PDB code: 5FIU)by 
molecular replacement using the original fluorinase crystal structure(PDB code: 1RQR).36 For direct 
comparison, the co-crystal structure of F2DA 7 was overlaid with that of FDA 2 and L-Met bound in 
the active site of the fluorinase.36 The structures are shown below in Figure 3, with the bright 
coloured structure and ligand with grey C-atoms belonging to the F2DA 7 structure, while pastel 
coloured structure and ligands with yellow C-atoms belonging to the FDA-L-Met structure. 
Binding of F2DA 7 does not result in any gross conformational change of the structure of the 
fluorinase, as shown in Figure 3 A. F2DA 7 was located in the active site, along with a molecule of 
tartrate (from the crystallisation buffer), as shown in Figure 3 B. Examination of the structure 
revealed that F2DA 7 engaged in numerous contacts to active site residues, as had been observed with 
other nucleosides co-crystallised with the enzyme. The adenine base was found to participate in pi-pi 
stacking interactions with Phe-254 and Trp-50, while the endo- and exo-cyclic nitrogen atoms formed 
hydrogen bonding interactions to Ala-279 and Asn-215. The 2',3'-diol system of the ribose ring was 
found to participate in a hydrogen bonding interaction with Asp-16. Tartrate occupies the L-Met 
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binding site, adopting a similar conformation to L-Met, where one of the carboxylates engages in 
polar interactions similar to those observed for carboxylate group of L-Met. 
Closer examination of the difluoromethyl group revealed that the fluorine atoms were located in the 
hydrophobic fluoride binding pocket. The interactions previously identified36 as important for reaction 
appeared conserved. One of the fluorine atoms lies 3.0 Å from the OH group of Thr-80, while the 
second fluorine makes contacts with the amide NH and side chain OH of Ser-150 (3.2 Å and 2.9 Å 
respectively). The two fluorine atoms appear to “share” the contacts usually observed between the 
protein and the fluorine atom of FDA 2. The hydrogen atom of the difluoromethyl group appears to 
engage in a weak hydrogen bonding interaction with one of the hydroxyl oxygen atoms of the co-
bound tartrate (CF2H–O distance = 2.1 Å), and does not form close contacts to any amino acid 
residues in the active site. 
 
Figure 3. A. Overlay of the structure of fluorinase bound to FDA 2 (pastel colours) and F2DA 7 (bright colours) showing no 
gross conformational change when bound to F2DA 7. B. F2DA 7 in the active site of the fluorinase, showing a 
hydrogen bonding contact between the hydrogen of the difluoromethyl group and one of the tartrate hydroxyl 
oxygens. The two monomers of the fluorinase shown in blue and red. The structure was obtained with a molecule 
of tartrate bound in the active site. C. Close up of the active site showing orientation of the fluorine atoms of 
F2DA 7 compared to the orientation of the C–F bond of FDA 2. Distances (Å) from the fluorine atoms to key 
residues are shown for FDA 2 (yellow dashes) and F2DA 7 (grey dashes). 
The adenine bases overlay well, as does the ribose ring. It is clear in Figure 3 C that the fluorine atom 
of FDA 2, the natural product, lies between the two fluorine atoms of the difluoromethyl group of 
F2DA 7. The location of the two fluorine atoms and their suggested interactions with Thr-80 and Ser-
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158, as shown above, support the suggestion that the fluoromethyl group bridges the interactions 
usually engaged by the single fluorine atom of FDA 2.  
The C–F bond is the strongest single bond observed in organic molecules, having a bond dissociation 
energy, on average, of 105.4 kJ.mol−1.37 In aliphatic systems, fluoride is well characterised as a poor 
leaving group38 a consequence of the strength of the C–F bond. The fluorinase enzyme has, however, 
uniquely evolved the ability to catalyse the cleavage of the C-F, bond with L-Met as an incoming 
nucleophile. Analogous chemical transformation has also been reported, using a range of Lewis acid 
or hydrogen bond catalysts to activate fluoride as a leaving group.39 Substitution of both fluorine 
atoms in difluoromethylene and difluoromethyl groups is an even more challenging transformation. 
The addition of a second electronegative fluorine atom at is expected to increase the strength of each 
of the C–F bonds, due to increased positive character at carbon.40 The non-bonding electrons of the 
second fluorine atom are also expected to hinder approach of an incoming nucleophile.41 Despite this, 
substitution of such motifs has been reported using potent nucleophiles, such as LiAlH4,42 AlCl3 and 
AlMe3.43 
Together, these observations suggest a possible reason why F2DA 7 is not a substrate for the 
fluorinase. The “sharing” of key interactions between the two fluorine atoms as observed in the X-ray 
co-crystal structure may no longer sufficiently activate one of the fluorines for substitution by L-Met 
or L-SeMet. A second consequence of this “sharing” of interactions is that neither of the fluorine 
atoms are aligned in the optimal conformation for the SN2-type substitution catalysed by the 
enzyme5,6,36 with the incoming nucleophile, increasing the kinetic barrier to reaction. These two 
factors originating from the enzyme-substrate interactions, coupled to the inherently stronger C-F 
bond and more shielded C-5' centre may all contribute to a lack of observed reactivity for the 
difluoromethyl nucleoside F2DA 7.  
3. Conclusions 
The difluoromethyl group plays an important role in a range of pharmaceuticals and agrochemicals in 
light of its unique physicochemical properties. In this context, we were interested in applying the 
fluorinase enzyme to the synthesis of difluoromethyl groups. F2DA 7, a difluormethylated nucleoside, 
was found to bind to the fluorinase with a marginally larger Ka compared to that of the natural 
substrate, FDA 2. Assays were conducted where F2DA 7 was incubated with both L-Met, and the 
more potent nucleophile, L-SeMet. No reaction was observed in HPLC assays for either set of 
conditions, and increasing the concentration of the nucleophile did not result in a reaction. A co-
crystal structure of the fluorinase bound to F2DA 7 was obtained and suggested that the two fluorine 
atoms were “sharing” interactions with Ser-158 and Thr-80, the two residues in the active site 
responsible for activating the fluorine atom for substitution. As a result, the conformation of neither of 
the C–F bonds matched that observed for the C–F bond in FDA 2, suggesting that the geometry of the 
bond was no longer optimal for SN2 attack by sulfur or selenium. These observations, coupled to the 
inherently stronger C–F bond observed in –CF2H compared to –CFH2 motifs, most probably 
contributes to a prohibitive reaction barrier.  
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Highlights 
The fluorinase is challenged with a difluoromethyl rather than a monofluoromethyl substrate 
5’,5’-Difluoro-5’-deoxyadenosine binds well to the fluorinase 
A co-crystal of the fluorinase and 5’,5’-difluoro-5’-deoxyadenosine is reported 
5’,5’-Difluoro-5’-deoxyadenosine is not a substrate for the fluorinase enzyme 
 
 
